Microbial resistance has progressed rapidly and is becoming the leading cause of death globally. The spread of antibiotic-resistant microorganisms has been a significant threat to the successful therapy against microbial infections. Scientists have become more concerned about the possibility of a return to the pre-antibiotic era. Thus, searching for alternatives to fight microorganisms has become a necessity. Some bacteria are naturally resistant to antibiotics, while others acquire resistance mainly by the misuse of antibiotics and the emergence of new resistant variants through mutation. Since ancient times, plants represent the leading source of drugs and alternative medicine for fighting against diseases. Plants are rich sources of valuable secondary metabolites, such as alkaloids, quinones, tannins, terpenoids, flavonoids, and polyphenols. Many studies focus on plant secondary metabolites as a potential source for antibiotic discovery. They have the required structural properties and can act by different mechanisms. This review analyses the antibiotic resistance strategies produced by multidrug-resistant bacteria and explores the phytochemicals from different classes with documented antimicrobial action against resistant bacteria, either alone or in combination with traditional antibiotics.
Uropathogenic Escherichia coli has a propensity to build biofilms to resist host defense and antimicrobials. Recurrent urinary tract infection (UTI) caused by multidrug-resistant, biofilm-forming E. coli is a significant public health problem. Consequently, searching for alternative medications has become essential. This study was undertaken to investigate the antibacterial, synergistic, and antibiofilm activities of catechin isolated from Canarium patentinervium Miq. against three E. coli ATCC reference strains (ATCC 25922, ATCC 8739, and ATCC 43895) and fifteen clinical isolates collected from UTI patients in Baghdad, Iraq. In addition, the expression of the biofilm-related gene, acrA, was evaluated with and without catechin treatment. Molecular docking was performed to evaluate the binding mode between catechin and the target protein using Autodock Vina 1.2.0 software. Catechin demonstrated significant bactericidal activity with a minimum inhibitory concentration (MIC) range of 1–2 mg/mL and a minimum bactericidal concentration (MBC) range of 2–4 mg/mL and strong synergy when combined with tetracycline at the MBC value. In addition, catechin substantially reduced E. coli biofilm by downregulating the acrA gene with a reduction percent ≥ 60%. In silico analysis revealed that catechin bound with high affinity (∆G = −8.2 kcal/mol) to AcrB protein (PDB-ID: 5ENT), one of the key AcrAB-TolC efflux pump proteins suggesting that catechin might inhibit the acrA gene indirectly by docking at the active site of AcrB protein.
22 February 2020 in Current Trends in Biotechnology and Pharmacy
Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa have been identified as major constituents of multidrug-resistant (MDR) bacteria, representing a substantial concern to global health. This study aims to test the antibacterial, biofilm-inhibitory, and synergistic effects of (+)-catechin against the three ATCC reference S. aureus strains (29213, 9144, and 25923), two ATCC reference P. aeruginosa strains (10145 and 9027), and MDR clinical isolates (n = 30) collected from urinary tract infections in patients from Baghdad, Iraq. In silico and in vitro models were used to evaluate the influence of catechin on the expression of genes involved in the formation of P. aeruginosa and MRSA biofilms. Synergistic interactions with seven antimicrobials were also evaluated. Catechin showed significant antibacterial activity against MRSA and P. aeruginosa (MIC ranges of 1–4 µg/mL and 2–8 µg/mL, respectively) with biofilm inhibition of ≥ 60% for MRSA and ≥ 75% for P. aeruginosa. Strong synergism was observed with the catechin-azithromycin combination against both bacteria: MRSA (80% synergy) and P. aeruginosa (100% synergy). Catechin showed high affinity for the FnbA protein in MRSA and the AlgD protein in P. aeruginosa according to in silico and gene expression analysis. This study represents the first report of the downregulation of the biofilm-associated protein AlgD in P. aeruginosa and FnbA in MRSA. However, further in vitro assays to explore the full mechanism behind catechin action is warranted.